BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT07198724-completion@plaintrial.com
DTSTAMP:20261029T143912Z
DTSTART;VALUE=DATE:20380601
SUMMARY:ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deru
 xtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-
 low or HER2-ultralow Metastatic Breast Cancer — estimated completion dat
 e
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT07198724
URL:https://plaintrial.com/trial/NCT07198724
END:VEVENT
END:VCALENDAR